Cargando…

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

BACKGROUND: Determination of β-amyloid (Aβ) positivity and likelihood of underlying Alzheimer’s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and Aβ within the normal range may still have a substantial risk of developing dementia, prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenberg, Anna, Solomon, Alina, Jelic, Vesna, Hagman, Göran, Bogdanovic, Nenad, Kivipelto, Miia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896336/ https://www.ncbi.nlm.nih.gov/pubmed/31805990 http://dx.doi.org/10.1186/s13195-019-0557-1

Ejemplares similares

β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population
por: Rosenberg, Anna, et al.
Publicado: (2022)

Cortisol, cognition and Alzheimer’s disease biomarkers among memory clinic patients
por: Holleman, Jasper, et al.
Publicado: (2022)

Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer’s Disease, and Dementia: From FINGER to World-Wide FINGERS
por: Rosenberg, A., et al.
Publicado: (2019)

Association of Sarcopenia and Its Defining Components with the Degree of Cognitive Impairment in a Memory Clinic Population
por: Larsson, Liss Elin, et al.
Publicado: (2023)

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism
por: Smailovic, Una, et al.
Publicado: (2020)

Reduced Sympathetic Response to Head-Up Tilt in Subjects with Mild Cognitive Impairment or Mild Alzheimer's Dementia
por: Mellingsæter, Marte Rognstad, et al.
Publicado: (2015)

Longitudinal study of Alzheimer's disease biomarkers, allostatic load, and cognition among memory clinic patients
por: Adedeji, Dickson O., et al.
Publicado: (2023)

Lifestyle Factors Are Important Contributors to Subjective Memory Complaints among Patients without Objective Memory Impairment or Positive Neurochemical Biomarkers for Alzheimer's Disease
por: Miley-Akerstedt, Anna, et al.
Publicado: (2018)

Dementia prevention: current epidemiological evidence and future perspective
por: Mangialasche, Francesca, et al.
Publicado: (2012)

Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to APOE ε4
por: Smailovic, Una, et al.
Publicado: (2021)

Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire
por: Lee, Sun-Ju, et al.
Publicado: (2018)

Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders
por: Palmer, Katie, et al.
Publicado: (2021)

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
por: Wolfsgruber, Steffen, et al.
Publicado: (2014)

Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?
por: O'Caoimh, Rónán, et al.
Publicado: (2013)

Changes in Lifestyle, Behaviors, and Risk Factors for Cognitive Impairment in Older Persons During the First Wave of the Coronavirus Disease 2019 Pandemic in Finland: Results From the FINGER Study
por: Lehtisalo, Jenni, et al.
Publicado: (2021)

European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
por: Solomon, Alina, et al.
Publicado: (2018)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
por: Wei, Hong-Chun, et al.
Publicado: (2021)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology
por: Sun, Yan, et al.
Publicado: (2021)

Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia
por: Pekkala, Timo, et al.
Publicado: (2020)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
por: Pekkala, Timo, et al.
Publicado: (2020)

Clinical impact of [(18)F]flutemetamol PET among memory clinic patients with an unclear diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2019)

Assessment of verbal and visuospatial working memory in mild cognitive impairment and Alzheimer's dementia
por: Kessels, Roy P.C., et al.
Publicado: (2015)

Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment
por: Goodman, Michelle S., et al.
Publicado: (2018)

Cerebellar Cortex and Cerebellar White Matter Volume in Normal Cognition, Mild Cognitive Impairment, and Dementia
por: Zdanovskis, Nauris, et al.
Publicado: (2021)

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Publicado: (2021)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

Midlife work-related stress is associated with late-life cognition
por: Sindi, Shireen, et al.
Publicado: (2017)

Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia
por: Hattori, Yorito, et al.
Publicado: (2023)

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI
por: Ding, Xiuhua, et al.
Publicado: (2019)

The Positivity Effect on the Intensity of Experienced Emotion and Memory Performance in Mild Cognitive Impairment and Dementia
por: Gorenc-Mahmutaj, Lina, et al.
Publicado: (2015)

Qualitative Comparison of Semantic Memory Impairment in Patients with Amnestic Mild Cognitive Impairment Based on β-Amyloid Status
por: Kim, Ji Eun, et al.
Publicado: (2019)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
por: Sörensen, Arnd, et al.
Publicado: (2020)

Cerebral Amyloid Positivity Prediction Models Using Clinical Data in Subjects With Mild Cognitive Impairment and Dementia
por: Joo, Soo Hyun, et al.
Publicado: (2021)

The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes
por: Michaud, Tzeyu L., et al.
Publicado: (2017)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dgkpl0kuklsko2k4dotm7gbge3